Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Varicella

Phase 1Biologic

Varicella is one of 19 biologic programs targeting Chickenpox. It is currently in Phase 1.

1

Indications

14

Total Trials

0

Active Trials

18

Competitors

Pipeline

Status by Indication[3][1]

Indication

ChickenpoxActive, not recruiting

ChickenpoxPhase 1

Active, not recruiting

Competition

Competitive Landscape

22 competitors in Chickenpox

#DrugCompanyPhaseTrials

Zovirax

BBp Consulting, Inc

Hepatitis a Vaccine

Zostavax

Investigational Cancer Drug

Varilrix

MMR-Vaccine

Comparator TIV

Candidate Varicella Vaccine

Marketed Paracetamol

PCV 20

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Immunogenicity5 trials

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Completed· Sanofi logo

Sanofi·Phase 3·NCT03691610·950 enrolled

Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)

Completed· Merck & Co. logo

Merck & Co.·Phase 3·NCT00822237·598 enrolled

Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)

Completed· Merck & Co. logo

Merck & Co.·Phase 3·NCT00496327·100 enrolled

Show 2 more trials

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers

Completed· Sanofi logo

Sanofi·Phase 3·NCT03205371·1,183 enrolled

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

Completed· Novartis logo

Novartis·Phase 2·NCT00310856·175 enrolled

Pediatric3 trials

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Completed· Sanofi logo

Sanofi·Phase 3·NCT05794230·1,528 enrolled

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Completed· Sanofi logo

Sanofi·Phase 2·NCT04398706·852 enrolled

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Completed· Sanofi logo

Sanofi·Phase 3·NCT03673462·2,797 enrolled

Chickenpox2 trials

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00001125·60 enrolled

A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00000837·127 enrolled

Vaccine1 trial

A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Completed· Sanofi logo

Sanofi·Phase 2·NCT01049035·580 enrolled

Respiratory Syncytial Virus1 trial

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Terminated· Sanofi logo

Sanofi·Phase 3·NCT06397768·2,226 enrolled

2 more indications

Vaccination1 trial

Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV

Completed·HHospital Clinic of Barcelona·Phase 4·NCT00329251·26 enrolled

Long-term Follow-up1 trial

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

Completed· GSK logo

GSK·Phase 3·NCT00406211·398 enrolled

Sources

References

[1]
ClinicalTrials.gov — 14 trial records for Varicella. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Varicella compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Varicella. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 1[1]
Company: Sanofi

Related News